RE: could be an interesting Q1 2010For me this raises the question - When are they going to share the information with the shareholders?
Does anyone not think that scientific results submitted to the AACR are more detailed and comprehensive than the information we recieved in the news releases?
December 2nd - "Scientific results from recent testing of the Company's lead cancer drug compound (GAP-107B8) have been submitted to the American Association of Cancer Research (AACR)" - The deadline for submissions was December 1st, in the same Dec. 2nd release - "additional data from this testing program, will be announced as they become known and are fully analyzed by the company" Two totally contradictory statements in the same news release!
In other words... If they can make a submission to AACR then additional data is "known" and has been "fully analysed" !!!!